Email a Friend
Print ArticleProstate Cancer Health Center
News and Features Related to Prostate Cancer
-
Aspirin May Prevent Prostate Cancer Recurrence
Nov. 6, 2009 (Chicago) -- The use of anti-clotting drugs, including aspirin, appears to lower the odds that cancer will recur in men undergoing radiation treatment for prostate cancer, researchers report. "We found that taking an anticoagulant lowers the risk [of recurrence] by almost half," says Ke
Read Full Article -
Proton Boost May Thwart Prostate Cancer's Return
Nov. 4, 2009 (Chicago) -- A boost of a highly targeted form of radiation therapy may prevent prostate cancer from coming back, a study of nearly 400 men suggests. Ten years after treatment, only 7% of men who received a boost of proton therapy suffered a recurrence of their prostate cancer, compared
Read Full Article -
Is Prostate Cancer Overtreated?
Nov. 3, 2009 (Chicago) -- The majority of men with prostate cancer can be spared anti-hormone therapy -- and all of its side effects, including impotence, hot flashes, and liver problems, researchers say. Adding a short course of hormone-blocking therapy to radiation treatment extended the lives of
Read Full Article -
New Test Checks for Prostate Cancer Return
Oct. 19, 2009 -- Researchers say they have developed a highly sensitive prostate specific antigen (PSA) test that may identify prostate cancer patients who are likely to relapse after treatment. In a small study, published this week in the journal PNAS Early Edition, the test proved to be 300 times
Read Full Article -
Robot Prostate Surgery: More ED, Incontinence
Oct. 13, 2009 - Minimally invasive prostate surgery -- often performed using a high-tech robot -- carries a higher risk of incontinence and erectile dysfunction than does open surgery. However, the newer technique cuts patients' hospital stays, requires far fewer blood transfusions, and carries less
Read Full Article -
Prostate Cancer Therapies Raise Heart Risk
Sept. 23, 2009 (Berlin) -- The anti-hormone therapies used to treat prostate cancer can raise the risk of heart disease, but some drugs appear to be safer for the heart than others, researchers report. The study, the largest to date to look at the issue, suggests that overall, anti-hormone therapies
Read Full Article -
Survival Improves for Prostate Cancer
Sept. 15, 2009 -- Older men with early prostate cancer are far more likely to survive their disease without surgery or radiation today than they were just a few decades ago, a new study shows. Researchers analyzed outcomes among men older than 65 diagnosed with localized prostate cancer after the in
Read Full Article -
STD Linked to Prostate Cancer
Sept. 11, 2009 -- Infection with a common sexually transmitted disease (STD) may make men more vulnerable to the most deadly form of prostate cancer, new research suggests. Men in the study who had been infected with the STD trichomoniasis were only slightly more likely to develop prostate cancer ye
Read Full Article -
Virus Linked to Prostate Cancer
Sept. 8, 2009 -- A virus may be responsible for some prostate cancers and hold clues to the cause of the deadly disease, according to a new study. Xenotropic murine leukemia virus-related virus (XMRV) has been previously linked to leukemia and sarcomas in animals, but researchers say this has more r
Read Full Article -
PSA Test: More Harm Than Good?
Aug. 31, 2009 -- The PSA prostate cancer screening test does more harm than good, a new study suggests. How much harm and how much good? "For every man who avoids a prostate cancer death due to PSA screening, about 50 men have to be treated unnecessarily -- and a third of these men will have serious
Read Full Article
Indication
Uroxatral® (alfuzosin HCl 10 mg extended-release tablets) is an alpha1-blocker for the treatment of the signs and symptoms of BPH.
Important Safety Information
Do not take UROXATRAL if you have liver problems or if you are taking antifungal drugs like ketoconazole or itraconazole, or HIV drugs like ritonavir.
UROXATRAL can cause a sudden drop in blood pressure, especially when starting treatment. This may lead to fainting, dizziness, and lightheadedness. Do not drive, operate machinery, or do any dangerous activity until you know how UROXATRAL will affect you. This is especially important if you already have a problem with low blood pressure or take medicines to treat high blood pressure. There may be an increased risk of low blood pressure and fainting when taking UROXATRAL in combination with blood pressure medication or nitrates, or erectile dysfunction medication.
If considering cataract surgery (clouding of the eyes), tell your eye surgeon that you are currently taking UROXATRAL or have previously been treated with an alpha-blocker.
Before taking UROXATRAL, tell your doctor if you have kidney problems.
Also, tell your doctor if you or any family member(s) have or take medications for a rare heart condition known as congenital prolongation of the QT interval.
BPH and prostate cancer can cause the same symptoms. However, UROXATRAL is not a treatment for prostate cancer.
The most common side effects with UROXATRAL are dizziness, upper respiratory tract infection, headache, and tiredness.
Please see UROXATRAL full prescribing information.
Symptoms of an Enlarged Prostate
Sheldon Marks, MD, explains nearly everything you need to know about an enlarged prostate but were afraid to ask.
